Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GZMO -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (248)	3/23/2000 2:26:00 PM
From: Mike McFarland	Read Replies (3) \| Respond to of 438

Genzyme Molecular Oncology Announces Public Offering of 3,000,000 Shares of Common Stock ...so, where do you suppose these shares will be priced? Is $22 1/2 a fair price to pay for GZMO today knowing that something on the order of 70M is coming their way? In my mind this further distances GZMO from Genzyme Corp, and cements the idea that Genzyme Molecular Oncology has its own common stock intended to reflect its value and track its financial performance.